Synthesis and secretion of tumour necrosis factor-α by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts
- 31 August 1997
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 58 (3) , 139-147
- https://doi.org/10.1016/s0165-2478(97)00080-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproductsImmunology Letters, 1996
- Molecular characteristics of methylglyoxal-modified bovine and human serum albumins. Comparison with glucose-derived advanced glycation endproduct-modified serum albuminsProtein Journal, 1995
- Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processingNature, 1994
- beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.Journal of Clinical Investigation, 1993
- Synthesis and chromatography of 1,2-diamino-4,5-dimethoxybenzene, 6,7-dimethoxy-2-methylquinoxaline and 6,7-dimethoxy-2,3-dimethylquinoxaline for use in a liquid chromatographic fluorimetric assay of methylglyoxalAnalytica Chimica Acta, 1992
- Serum Levels of Tumor Necrosis Factor and IL-1α and IL-1β in Diabetic PatientsDiabetes Care, 1991
- Scavenger receptor of human monocytic leukemia cell line (THP-1) and murine macrophages for nonenzymatically glycosylated proteinsBiochimica et Biophysica Acta (BBA) - Biomembranes, 1989
- Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage.Journal of Clinical Investigation, 1989
- A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNFCell, 1988